###### Strengths and limitations of this study

Stratifying by the main risk factors that are active during the expulsive phase of labour and testing for confounders are strengths of the study.We reveal how oxytocin augmentation interacts with the major factors active in the expulsive phase of labour.The study is based on prospectively collected data from a large, unselected population, which makes bias unlikely.The study design is a limitation, as we cannot prove causality between oxytocin augmentation and obstetric anal sphincter injuries in an observational study.

Introduction {#s1}
============

Obstetric anal sphincter injuries occur in 0.5--5.0% of vaginal deliveries[@R1] with a subsequently increased risk of faecal incontinence.[@R2] Nulliparity,[@R1] [@R3] [@R5] high birth weight (BW),[@R1] [@R3] [@R5] [@R6] operative vaginal delivery,[@R1] [@R3] [@R5] advanced maternal age,[@R1] [@R5] [@R6] Asian or African ethnicity,[@R1] [@R7] and prolonged second stage of labour[@R3] [@R7] [@R8] are consistently reported as risk factors for obstetric anal sphincter injuries, whereas the effect of epidural analgaesia[@R9] [@R10] and episiotomy[@R1] [@R11] is debated. However, only a few authors have evaluated oxytocin augmentation as a possible risk factor for obstetric anal sphincter injuries.[@R5] [@R14] [@R15] Further, the current literature dealing with risk factors for obstetric anal sphincter injuries has not sufficiently addressed their possible interactions. Studies usually present a summary of associations between risk factors and obstetric anal sphincter injuries adjusted for confounders without investigating effect modification, that is, exploring whether the effects are uniform across various levels of the studied risk factors.

In many delivery units, oxytocin augmentation is used during more than half of births.[@R16] [@R17] Oxytocin augmentation has been shown to shorten the duration of labour, but not to decrease the need for operative deliveries.[@R18] We hypothesise that oxytocin augmentation may reduce control over contractions and impair perineal support by causing the delivery to progress too quickly, and thereby increase the risk of perineal injury. Thus, the widespread use of oxytocin in daily obstetric practice calls for an exploration of its possible harmful effects. The aim of our study was to assess the association between oxytocin augmentation and obstetric anal sphincter injuries in a dynamic model related to the active second stage of labour.

Materials and methods {#s2}
=====================

The Department of Obstetrics and Gynecology of Stavanger University Hospital serves as the only delivery unit for a population of 320 000 people, and approximately 4500 deliveries occur there annually. From 1996 onward, all obstetric data have been consecutively recorded. The electronic database consists of clearly defined variables, and is continuously maintained using standardised procedures for data entry and quality control. During the study period, 15 May 1999 to 15 May 2012, 56 517 women with a pregnancy duration of ≥23 weeks of gestation delivered infants with a BW of \>300 g in the department. Estimated day of delivery was determined by second trimester ultrasound scan or from menstrual data when no ultrasound examination was performed. We restricted the study population to nulliparous women whose labour started spontaneously, with single cephalic presentation, pregnancies of ≥37 weeks of gestation (Group 1 in Robson's Ten Group Classification System; TGCS[@R19]) and who delivered vaginally. After excluding 69 women with missing data (52 without an estimated day of delivery, 17 with missing information of fetal presentation at delivery), this case--control study comprised 15 476 women.

The main outcome measure was obstetric anal sphincter injuries as defined by the International Continence Society, that is, partial or complete tears of the anal sphincter muscles, with or without disruption of the anal mucosa (grades 3--4 perineal tears).[@R20] When an obstetric anal sphincter injury was suspected, the obstetrician on call diagnosed the grade of the tear during surgical repair.

Oxytocin augmentation was defined as oxytocin used to stimulate contractions during established labour. An intravenous infusion of 5 international units (0.01 mg) of oxytocin in 500 mL saline was administered, starting with 30 mL/h and a dose increment of 15 mL/h every 15 min to a maximum of 180 mL/h, guided by the response. Normal births were taken care of by midwives, while doctors performed the operative deliveries. Throughout the study period, episiotomy was performed either mediolaterally or laterally. According to our routines and national guidelines, operative vaginal delivery was indicated if delivery had not taken place after 60 min of bearing down. We used vacuum extraction with a Malmström metal cup as the preferred procedure for operative vaginal delivery. Vacuum extraction was applied for mid-cavity and outlet release. A combination of low-dose ropivicaine/fentanyl was used for epidural analgaesia. Ethnicity was classified as Western, that is, originating from Europe or North America, or non-Western.

The intention of this study was to explore the effect of three obstetric practices (oxytocin augmentation (O), episiotomy (E) and vacuum/forceps (VF)) and BW on obstetric anal sphincter injuries before other risk factors were considered. These main risk factors correlate as episiotomy is often used for instrumental deliveries and when large babies are expected. Furthermore, oxytocin augmentation is provided for failure to progress because of dystocia. Women with dystocia are more often delivered instrumentally than women without dystocia. This basic understanding of the birth dynamics of the first and second stages of labour indicates that the main risk factors may have a direct or indirect effect on obstetric anal sphincter injuries, and that the effects of categories across different explanatory variables are not constant on the outcome.

We analysed our dataset using the χ^2^ test and backward manual stepwise logistic regression analyses with p\<0.05 as significance level. We built and checked the fit of our regression model as proposed by Agresti.[@R21] Step one compares the model including the highest order four-way interaction with a model without the four-way interaction. If the highest order product is not significant, Agresti proposes continuing by removing the highest order term with the highest non-significant p value until all remaining terms have statistically significant p values. Four main predictors (O, E, VF and BW) are used to predict the proportions of women with sphincter injuries. Confounders, possible risk factors in addition to the main factors of interest, were tested one by one and set to at least 10% change in any estimate in the model of best fit. Interaction terms were significant at p\<0.05. Statistical analyses were performed with IBM SPSS Statistics for Windows, V.19.0, IBM Corp, Armonk, New York, USA.

The Regional Committee for Medical and Health Research Ethics, Western Norway, approved the protocol as a quality assurance study in obstetric care, and fulfilling the requirements for data protection procedures (REK 2011-1247).

Results {#s3}
=======

The study population comprised 15 476 (27%) of the 56 517 women giving birth during the study period, including 1013 (53%) of a total of 1894 women diagnosed with obstetric anal sphincter injuries.

The overall prevalence of obstetric anal sphincter injuries was 6.5%. The rate declined from 9.6% in 1999--2000 to 2.8% in 2010--2012. The characteristics of the study population and the prevalence of obstetric anal sphincter injuries are displayed in [table 1](#BMJOPEN2013004592TB1){ref-type="table"}.

###### 

Characteristics of the study population and the prevalence of obstetric anal sphincter injury

                                     Obstetric anal sphincter injury   In total N=15 476   Prevalence Per cent   p Value   
  ---------------------------------- --------------------------------- ------------------- --------------------- --------- ---------
  Time period                                                                                                              \<0.001
   1999--2000                        11.1                              16.9                1781                  9.6       
   2001--2003                        19.8                              30.7                3169                  9.8       
   2004--2006                        22.9                              29.6                3611                  8.3       
   2007--2009                        25.5                              14.3                3826                  3.8       
   2010--2012                        20.8                              8.6                 3089                  2.8       
  *Maternal factors*                                                                                                       
  Age (years)                                                                                                              \<0.001
   \<25                              26.6                              19.3                4040                  4.9       
   25--29                            33.5                              37.6                5233                  7.3       
   30--34                            17.8                              20.8                2785                  7.6       
   ≥35                               22.1                              22.2                3418                  6.6       
  Origin                                                                                                                   NS\*
   Western                           90.5                              92.0                14 025                6.6       
   Non-Western                       9.5                               8.0                 1451                  5.6       
  *Obstetric factors*                                                                                                      
  Epidural analgaesia                                                                                                      NS
   No                                58.1                              57.7                8992                  6.5       
   Yes                               41.9                              42.3                6484                  6.6       
  Oxytocin augmentation                                                                                                    \<0.001
   No                                55.6                              44.7                8500                  5.3       
   Yes                               44.4                              55.3                6976                  8.0       
  Active 2nd stage of labour (min)                                                                                         \<0.001
   Missing information               0.6                               0.3                 92                    3.3       
   0--14                             10.8                              6.8                 1627                  4.2       
   15--29                            26.8                              18.5                4063                  4.6       
   30--59                            40.1                              37.8                6181                  6.2       
   ≥60                               21.7                              36.6                3513                  10.6      
  Episiotomy                                                                                                               NS
   No                                67.1                              65.4                10 372                6.4       
   Yes                               32.9                              34.6                5104                  6.9       
  Operative vaginal delivery                                                                                               \<0.001
   No                                77.5                              60.3                11 817                5.2       
   Yes                               22.5                              39.7                3659                  11.0      
  *Fetal factors*                                                                                                          
  Birth weight (g)                                                                                                         \<0.001
   \<4000                            87.8                              74.2                13 454                5.6       
   ≥4000                             12.2                              25.8                2022                  12.9      
  Occiput posterior position                                                                                               NS
   No                                95.4                              94.8                14 771                6.5       
   Yes                               4.5                               5.2                 705                   7.4       

p Values from χ^2^ tests.

\*Non-significant.

The prevalence was higher in women who received oxytocin augmentation (8.0% vs 5.3%), those who were delivered instrumentally (11.0% vs 5.2%) and in those who gave birth to an infant weighing ≥4000 g (12.9% vs 5.6%). Furthermore, the prevalence increased with longer durations of the active part of the second stage of labour.

After adopting the strategy of Agresti by deleting the highest statistically non-significant terms in the model until all remaining terms are statistically significant, we ended up with a best fitting model involving the three-way interaction of oxytocin augmentation, episiotomy and vacuum/forceps (O×E×VF) and the two two-way interactions episiotomy/birth weight (E×BW) and vacuum/forceps (VF×BW) (model A). We could resolve interaction terms into stratified analysis of eight strata of combinations of oxytocin augmentation, episiotomy and instrumental delivery for BW \<4000 g, and four strata of combinations of episiotomy, instrumental delivery and BW ≥4000 g, independent of oxytocin augmentation. The results are displayed in [table 2](#BMJOPEN2013004592TB2){ref-type="table"}.

###### 

Model A: Stratified analyses of eight strata of combinations of oxytocin augmentation, episiotomy, instrumental delivery and birth weights \<4000 g, and four strata of episiotomy, instrumental delivery and birth weights ≥4000 g, independent of oxytocin augmentation

  -----------------------------------------------------------------------------------------------------------------------------------------
  Group   Oxytocin augmentation\*   Episiotomy\*   Operative vaginal delivery\*   Birth weight†   Women\   OASI‡\       OR    95% CI
                                                                                                  N        N (%)              
  ------- ------------------------- -------------- ------------------------------ --------------- -------- ------------ ----- -------------
  1       −                         −              −                              −               5328     198 (3.7)    1.0   

  2       −                         \+             −                              −               1434     60 (4.2)     1.1   0.8 to 1.5

  3       −                         \+             \+                             −               537      43 (8.0)     2.3   1.6 to 3.2

  4       −                         −              \+                             −               316      47 (14.9)    4.5   3.2 to 6.4

  5       \+                        \+             \+                             −               1283     92 (7.2)     2.0   1.6 to 2.6

  6       \+                        −              \+                             −               896      103 (11.5)   3.4   2.6 to 4.3

  7       \+                        −              −                              −               2621     148 (5.6)    1.6   1.3 to 1.9

  8       \+                        \+             −                              −               1039     61 (5.9)     1.6   1.2 to 2.2

  9       +/--                      \+             −                              \+              418      40 (9.6)     2.7   1.9 to 3.9

  10      +/−                       −              −                              \+              977      104 (10.6)   3.1   2.4 to 4.0

  11      +/−                       \+             \+                             \+              393      55 (14.0)    4.2   3.1 to 5.8

  12      +/−                       −              \+                             \+              234      62 (26.5)    9.3   6.8 to 12.9
  -----------------------------------------------------------------------------------------------------------------------------------------

Crude OR and 95% CIs.

\*Used (+)/unused (−).

†≥4000 g (+)/\<4000 g (−).

‡Obstetric anal sphincter injury.

From a clinical perspective we can simplify model A into model B by collapsing groups that comprise similar risks for sphincter injury by obstetric interventions despite overlapping CIs. Spontaneous delivery of an infant weighing \<4000 g without oxytocin augmentation and episiotomy was chosen as the reference group (group 1). We collapsed groups 1 and 2 as the OR for sphincter injury was similar with and without episiotomy in unstimulated, spontaneous births of normal-size infants. Groups 3 to 6 displayed the OR for sphincter injury in instrumental deliveries of normal-size infants with and without oxytocin augmentation and episiotomy. A marked difference in the OR for sphincter injury was observed between women delivered instrumentally with (groups 3 and 5) and without (groups 4 and 6) episiotomy, despite the fact that those stimulated with oxytocin had a non-significant lower OR for sphincter injury. It was, therefore, reasonable to collapse groups 3 and 5 and groups 4 and 6. Furthermore, we collapsed groups 7 and 8 as the OR for sphincter injury was similar with and without episiotomy during spontaneous deliveries of infants \<4000 g, regardless of oxytocin augmentation. Finally, the use of episiotomy appeared to be strongly associated with lower OR for sphincter injury in instrumental deliveries of infants ≥4000 g (groups 11 and 12). The modified model B ([table 3](#BMJOPEN2013004592TB3){ref-type="table"}) comprises a clinically relevant risk estimation of anal sphincter injury among the main modified risk factors for sphincter injury.

###### 

Modified model displaying the collapsed non-significant strata (1--12) from [table 2](#BMJOPEN2013004592TB2){ref-type="table"} into new strata (A--G)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Group (group in [table 2](#BMJOPEN2013004592TB2){ref-type="table"})   Oxytocin augmentation\*   Episiotomy\*   Operative vaginal delivery\*   Birth weight†   Women\   OASI‡\       OR    aOR (95% CI)
                                                                                                                                                                N        N (%)              
  --------------------------------------------------------------------- ------------------------- -------------- ------------------------------ --------------- -------- ------------ ----- --------------------
  A (1,2)                                                               −                         +/−            −                              −               6762     258 (3.8)    1.0   1.0

  B (7,8)                                                               \+                        +/−            −                              −               3660     209 (5.7)    1.5   1.8 (1.5 to 2.2)

  C (3,5)                                                               +/−                       \+             \+                             −               1820     135 (7.4)    2.0   2.3 (1.8 to 2.8)

  D (4,6)                                                               +/−                       −              \+                             −               1212     150 (12.4)   3.6   4.1 (3.3 to 5.1)

  E (9--10)                                                             +/−                       +/−            −                              \+              1395     144 (10.3)   2.9   3.1 (2.5 to 3.9)

  F (11)                                                                +/−                       \+             \+                             \+              393      55 (14.0)    4.1   4.7 (3.4 to 6.5)

  G (12)                                                                +/−                       −              \+                             \+              234      62 (26.5)    9.1   10.5 (7.6 to 14.4)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Unadjusted OR, adjusted (aOR) and 95% CIs after adjusting for epidural analgaesia.

\*Used (+)/unused (−).

†≥4000 g (+)/\<4000 g (−).

‡Obstetric anal sphincter injury.

Age, origin of the mother and occiput posterior position had no confounding effect on ORs for obstetric anal sphincter injury across combinations of episiotomy, oxytocin augmentation, operative vaginal delivery and BW (groups A to G in [table 3](#BMJOPEN2013004592TB3){ref-type="table"}).

The unadjusted OR for the presence or absence of epidural analgaesia was 1.02; however, the adjusted OR for epidural analgaesia was 0.73, (95% CI 0.63 to 0.84), that is, epidural analgaesia was associated with a 30% lower OR of anal sphincter injury.

The use of oxytocin augmentation increased with the duration of the second stage of labour over all the time periods from an average of 32% in the \<30 min group, 46% in the 30--59 min group, and 65% (range 49--76%) in the ≥60 min group during the active second stage of labour. The prevalence of operative deliveries across all study periods was consistently between 45% and 49% when the active part of the second stage of labour lasted ≥60 min versus 12--21% for durations of the second stage of labour of \<60 min. We found strong associations between oxytocin augmentation and the duration of the second stage, and between operative delivery and the duration of the second stage (collinearity), which means that the duration of the second stage is measured through operative delivery and oxytocin augmentation.

Discussion {#s4}
==========

We found that oxytocin augmentation during active labour was associated with a 80% increased OR of obstetric anal sphincter injury in women in TGCS group 1 giving spontaneous birth to an infant weighing \<4000 g. We did not find an association between episiotomy and tears during spontaneous deliveries, but a significantly reduced association in all operative vaginal deliveries.

Oxytocin augmentation is widely used in delayed labour to prevent operative delivery. However, a Cochrane review concluded that a reduction of labour by 2 h was the only proven effect, and there was no effect on operative deliveries.[@R18] Another recent review found the entire concept of active management of labour to be associated with a slightly reduced risk of caesarean delivery.[@R22] As in other studies, we found that approximately 50% of nulliparous women received oxytocin augmentation.[@R16] [@R17] [@R23] There is reason to believe that guidelines for the diagnosis and treatment of protracted labour are unclear or inconsistently applied in daily practice.[@R17] We hypothesise that stimulation with oxytocin may speed up the progress of the expulsive phase of labour leading to rushed situations, impaired communication with the mother, less focus on protection of the perineum and a controlled delivery of the head. Recent studies from Norway indicate that focus on these elements is important in preventing perineal injuries.[@R24] [@R25]

Many authors have used logistic regression analysis to identify risk factors for obstetric anal sphincter injuries, but only a few have included oxytocin augmentation. Samuelsson *et al*,[@R14] Prager *et al*,[@R15] and Jander and Lyrenas[@R5] found oxytocin augmentation to be predictive of obstetric anal sphincter injuries in univariate analysis, but only Jander and Lyrenas confirmed this finding in multivariable analyses. Samuelsson *et al*[@R14] did not stratify by parity, which is a methodological weakness since the true effect of other factors is concealed by the strong impact of parity. Prager *et al*[@R15] studied obstetric anal sphincter injuries in nulliparous women, entering oxytocin augmentation, duration of active second stage of labour and instrumental delivery into the same model.

Our study shows strong collinearity between a prolonged active second stage of labour and both oxytocin augmentation and instrumental delivery. We consider the duration of the active second stage of labour to be a 'proxy' for oxytocin augmentation and instrumental delivery, and not a risk factor for obstetric anal sphincter injury in itself. Long duration of the second stage is a time-related event before the expulsion of the head. During this latency the active forces do not inflict injury on the sphincter apparatus, the sphincter injury occurs during the expulsive phase. Consequently, we do not consider the duration of the active second stage as a risk factor for anal sphincter injuries.

Jander and Lyrenas[@R5] conducted a single institution, retrospective, case--control study of 214 cases to explore 44 possible risk factors, and found that oxytocin augmentation was a significant risk factor for obstetric anal sphincter injuries in multivariable analyses (OR 2.00; 95% CI 1.13 to 3.53). However, these researchers did not stratify by parity or state whether or not interactions were tested for. Furthermore, three older studies on the risk of obstetric anal sphincter injury included oxytocin use without differentiating whether oxytocin was provided for induction or augmentation purposes.[@R26] Three large population-based studies on the risk of obstetric anal sphincter injuries did not include oxytocin augmentation in their analyses.[@R1] [@R7] [@R8]

The influence of epidural analgaesia on anal sphincter injuries is unclear. Eskandar and Shet^9^ found a reduced risk, but did not stratify by parity. Dahl and Kjølhede^10^ found epidural analgaesia to be an independent protective factor in nulliparous women. Poen *et al*[@R29] stratified by parity and found a significantly increased OR associated with epidural analgaesia in nulliparous women. In our study, epidural analgaesia was associated with a significantly reduced OR for sphincter tears.

Our study takes into account four factors that exert their effect on the anal sphincter during the final minutes of delivery. As in previous studies,[@R1] [@R3] [@R5] we found both operative vaginal delivery and high BW to be strongly associated with obstetric anal sphincter injuries. We found episiotomy to be associated with a lower prevalence of sphincter tears in operative vaginal deliveries, but not in spontaneous births. This is consistent with a large national registry study from Norway,[@R1] but differs from other studies.[@R8] [@R11] [@R13] [@R30] [@R31] In our study, neither oxytocin augmentation nor episiotomy were associated with obstetric anal sphincter injury during spontaneous delivery of an infant weighing ≥4000 g.

Our methodological approach, stratifying by the factors that are active during the expulsive phase of labour and testing for confounders, is considered the strength of the study. This approach leads to a more detailed understanding of how oxytocin augmentation interacts with these major risk factors. Logistic regression analyses, without testing for possible interactions, would fail to reveal this information. This case--control study is based on prospectively collected data from a large unselected population, and represents all deliveries meeting the inclusion criteria that occurred during the study period, which make bias unlikely. Our department has a high proportion of vaginal deliveries. The overall caesarean delivery rate in our institution was 12.5% over the study period. For women in TGCS group 1 the acute caesarean section rate increased from 5.0% in 1999 to 7.5% in 2012. Accordingly, the study population includes both high-risk and low-risk pregnancies, which adds to the external validity of our results.

However, some limitations apply. We cannot prove causality between oxytocin augmentation and obstetric anal sphincter injuries in an observational study. Furthermore, socioeconomic status, smoking, body mass index, maternal delivery positions, perineal support technique and the birth attendant\'s experience level may be possible risk modifiers not included in our database. Finally, single institution studies, also when based on unselected populations, should be interpreted with caution.

Our findings have some important implications. Birth attendants should be aware of the association between oxytocin augmentation and obstetric anal sphincter injuries in the large subgroup of nulliparous women giving spontaneous birth to a normal-size infant. More restrictive use of oxytocin may help prevent obstetric anal sphincter injuries. Implementation of evidence-based guidelines for using oxytocin augmentation should be encouraged. The WHO recommends the use of a partogram with an action line defining failure to progress. However, a recent Cochrane review could not confirm that such a partogram was beneficial in high resource settings.[@R32] Given the doubtful benefits from augmentation of labour, randomised controlled trials are strongly needed, and we propose anal sphincter injury as one of the most important endpoints.

Moreover, our study supports restricted use of episiotomy during normal births and as a recommendation for operative vaginal deliveries. BW is an important, albeit unpredictable risk factor as weight estimation of a large fetus is unreliable.[@R33]
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